Rejected at 10:59 p.m. Feb, 10, 2024 ] by Cameron
Author: salmanumer
Related Note: 1474340758802
Rationale for change

source: https://next.amboss.com/us/article/fh0kWf?utm_source=anki&utm_medium=anki&utm_campaign=anki&utm_term=management%2Bof%2Bdvt&guid=hV%2525zJ%2560%2F%2F%253E0&aid=ee320c7d-b512-4f0d-8562-e858e936fcc1&uid=Dwsf1OCna#Zcf2e88d83f831204a68eef931762d749
statement similar to nid 1474340761077
"{{c1::Direct oral anticoagulants (e.g. rivaroxoban, apixaban)}} are used for treatment and long-term prevention of DVT"

heparin is used for prophylaxis in pregnant pts or those with recurrent dvts despite adequate treatment with other agents

Rejection reason

Will leave as is for now, please resubmit if you think my understanding is incorrect

Text Text
Extra Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid

Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Empty field
Physeo

OME

Additional Resources
prevent future clots from forming, which will kill the person
One by one
Empty field
#AK_Step2_v12::#Resources_by_rotation::Surgery::nbme::form_1 #AK_Step2_v12::#SketchySurgery::02_Trauma,_Burns,_Critical_Care::03_Abdominal_Trauma::Retired_Lesson::06_Pelvic_Trauma_[OLD_VERSION] #AK_Original_Decks::Step_1::Zanki_Step_Decks::Zanki_Respiratory::Respiratory_Pathology #AK_Step1_v12::#B&B::11_Hematology::01_Hemostasis::07_Anticoagulant_Drugs #AK_Step1_v12::#Pathoma::04_Hemostasis::04_Thrombosis #AK_Step1_v12::#SketchyPharm::03_Blood_&_Inflammation::01_Anticoagulants_&_Thrombolytics::01_Heparin,_LMWH,_fondaparinux,_direct_thrombin_inhibitors,_Xa_inhibitors #PANCE::EOR::Surgery #AK_Step1_v12::#UWorld::Step::529 #AK_Step1_v12::#UWorld::COMLEX::23642 #AK_Step2_v12::#AMBOSS::KQaUC4 #AK_Step1_v12::#B&B::18_Pulm::03_Other_Pulmonary_Topics::08_Pulmonary_Embolism #PANCE::EOR::EM #AK_Step1_v12::^Other::^EXPN::Uworld #AK_Step2_v12::#NBME #AK_Step1_v12::#FirstAid::16_Respiratory::04_Pathology::04_Deep_venous_thrombosis::*DVT #AK_Step1_v12::#UWorld::COMLEX::24188 #AK_Step2_v12::#B&B::07_Hematology_and_Oncology::02_Coagulation::05_Anticoagulants #AK_Step2_v12::#SketchySurgery::02_Trauma,_Burns,_Critical_Care::04_Head_and_Neck_Trauma::05_Moderate_and_Severe_Traumatic_Brain_Injury_2_Management #AK_Step1_v12::#Bootcamp::Pulmonology::08_Lung_Pathology_Special_Topics::01_DVT_and_Pulmonary_Embolism #AK_Step1_v12::^Other::^HighYield::1-HighYield #AK_Step1_v12::#UWorld::COMLEX::24305 #AK_Step1_v12::^Systems::Respiratory::Pathology #AK_Step2_v12::!Shelf::Surgery::no_dupes #PANCE::EOR::IM #AK_Step1_v12::#AMBOSS::KQaUC4 #AK_Step1_v12::#UWorld::Step::1077 #AK_Step1_v12::#Physeo::09_Pharm::17_Hem/Onc_Pharm::01_Heparin_LMWH_Fondaparinux #AK_Step2_v12::#UWorld::#UWSA2 #AK_Step2_v12::Original_decks::Dorian::surg::nbme::1 #PANCE::EOR::Family_med #AK_Step2_v12::#Resources_by_rotation::Surgery::nbme::form_6 #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step3_v12::#UWorld::5931 #AK_Step2_v12::#Resources_by_rotation::IM::nbme::form_8 #AK_Step2_v12::#AMBOSS #AK_Step1_v12::#Physeo::11_Pathology::03_Pulmonary_Pathology::04_DVT #AK_Step1_v12::#SketchyPath::03_Pulmonary::03_Acute_Lung_Disorders::03_Deep_Vein_Thrombosis_&_Pulmonary_Embolism #AK_Step1_v12::#OME::Clinical::Internal_Medicine::Hematology-Oncology::Approach_To_Bleeding #AK_Step1_v12::^Other::^EXPN::BGedit #AK_Step1_v12::#UWorld::Step::1194 #AK_Step1_v12::#Bootcamp::Hematology_and_Oncology::07_Coagulation_and_Fibrinolysis::10_Anticoagulation #AK_Step2_v12::#SketchyIM::01_Cardiology::05_Blood_Vessel_Disease::01_DVT_SOAP #AK_Step2_v12::#AMBOSS::-GaDbm #AK_Step2_v12::#UWorld::Step::7527 #PANCE::CARDIO::vascular_disease !AK_UpdateTags::Step1decks::Zanki-Step-Decks::Zanki-Respiratory::Respiratory-Pathology #AK_Step1_v12::#COMBANK::Assessment_2